Digital Approaches for Managing Brain Fog in ME/CFS: Interventions, Monitoring, and Future Directions, 2026, Araja

[Dolphin]

https://www.mdpi.com/2075-1729/16/4/571

Digital Approaches for Managing Brain Fog in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Interventions, Monitoring, and Future Directions​

by
Diana Araja
1,*<i></i>,
Modra Murovska
1<i></i>,
Angelika Krumina
2<i></i>,
Ajandek Eory
3<i></i> and
Uldis Berkis
4<i></i>


1
Institute of Microbiology and Virology, Riga Stradins University Research Center, Riga Stradins University, 5 Ratsupites Str., LV-1067 Riga, Latvia
2
Department of Infectology, Riga Stradins University, 16 Dzirciema Str., LV-1007 Riga, Latvia
3
Division of Integrative Medicine, Department of Family Medicine, Semmelweis University, 7-9 Stahly Str., H-1085 Budapest, Hungary
4
Department of Development and Projects, Riga Stradins University, 16 Dzirciema Str., LV-1007 Riga, Latvia
*
Author to whom correspondence should be addressed.
Life 2026, 16(4), 571; https://doi.org/10.3390/life16040571
Submission received: 29 January 2026 / Revised: 11 March 2026 / Accepted: 24 March 2026 / Published: 1 April 2026

Review Reports Versions Notes

Abstract​

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a high-burden, under-researched condition characterized by heterogeneous and fluctuating symptoms, including cognitive dysfunction commonly described by patients as “brain fog”.

Despite growing interest in digital health technologies for symptom monitoring and personalized care, their application to the assessment and management of cognitive dysfunction in ME/CFS remains unclear.

This descriptive review aimed to examine the current scientific evidence on digital approaches related to brain fog in ME/CFS.

A structured literature search following PRISMA guidance was conducted to identify relevant studies.

The available literature remains limited in scope and methodological maturity.

During synthesizing across studies, three main functional domains of digital application become apparent:
(1) digital tools for cognitive assessment, which have the strongest evidence base;
(2) digital platforms for longitudinal monitoring;
and
(3) digitally mediated interventions or rehabilitation approaches, both of which are less well studied.

Simultaneously, the findings suggest that patient-reported brain fog may represent a visible component of the broader ME/CFS disease spectrum and could serve as an early clinical indicator guiding diagnosis and management.

Interpreting these symptoms within a biopsychosocial framework may facilitate understanding of the complex nature of the disease and optimize the use of digital technologies for monitoring cognitive dysfunction and supporting patient-centered care in ME/CFS.

Keywords:
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); cognitive impairment; brain fog; digital health; digital biomarkers; cognitive assessment; remote monitoring; biopsychosocial framework; patient-centered care

 

[Utsikt]

Interpreting these symptoms within a biopsychosocial framework may facilitate understanding of the complex nature of the disease and optimize the use of digital technologies for monitoring cognitive dysfunction and supporting patient-centered care in ME/CFS.

Sure, that’s what the research tells us..

The limitations are substantial, but it doesn’t stop them from making recommendations:

4.3. Strength of Evidence and Methodological Limitations​

Despite these promising developments, the methodological strength of the available evidence varies considerably. A number of studies involved small sample sizes or exploratory designs, limiting their statistical power and generalizability. Several digital approaches were evaluated in single-case studies or pilot cohorts, including multi-omics integration in an individual patient and exploratory therapeutic interventions. Such studies provide valuable proof-of-concept insights but should be interpreted cautiously and cannot establish clinical efficacy.

Similarly, some investigations remained protocol descriptions rather than completed trials, while others relied on cross-sectional observational data. Neuroimaging studies, although technically sophisticated, often involve modest sample sizes and may reflect highly selected patient populations. In addition, cognitive outcomes were assessed using heterogeneous instruments and metrics across the studies, complicating direct comparison or synthesis.

Another important limitation concerns validation and disease specificity. Many digital cognitive tools applied in ME/CFS research were originally developed for other neurological or psychological conditions and have not been specifically validated in ME/CFS populations. While this reflects a pragmatic reuse of available technologies, it also raises questions regarding measurement sensitivity, ecological validity, and interpretability in the context of fluctuating fatigue-related cognitive symptoms.

Taken together, these factors suggest that the current evidence base should be viewed as emerging and exploratory rather than a mature clinical evidence base. Future research would benefit from larger, longitudinal studies with standardized cognitive endpoints, rigorous validation of digital biomarkers, and the integration of digital measures with clinical and biological data.

 

[rvallee]

Interpreting these symptoms within a biopsychosocial framework may facilitate understanding of the complex nature of the disease and optimize the use of digital technologies for monitoring cognitive dysfunction and supporting patient-centered care in ME/CFS.

There is no plausible or rational reason for this, and certainly no basis in fact. Wishful thinking is not a strategy.

So as future directions go, how about: no.

 

[Sean]

Interpreting these symptoms within a biopsychosocial framework may facilitate understanding of the complex nature of the disease and optimize the use of digital technologies for monitoring cognitive dysfunction and supporting patient-centered care in ME/CFS.​

That 'may' is doing an awful lot of heavy lifting.

And WTF does "patient-centred care" even mean? What were they practising before this lofty concept came along?